Skip to content

Search

Banksia Hill Project’s ripple effect

The two-year study, which was the first in Australia to assess and diagnose young people in a youth custodial setting for Fetal Alcohol Spectrum Disorder.

New friend to improve social attention of kids with autism

An attention-training game developed by researchers at The Kids Research Institute Australia is helping to improve social skill development in school-aged kids with autism.

Landmark folate research recognised as major public health achievement

The Public Health Association of Australia has rated mandatory folate fortification – which led to a dramatic decline in neural tube defects – as one of the top 10 public health achievements of the past two decades.

My child is wheezing – what should I do?

Almost 50 per cent of preschool children will experience at least one episode of wheeze, a whistling sound produced by the airways during breathing.

The Kids Email Alert (January 2018)

You may have received an email claiming to be from The Kids Research Institute Australia with an outstanding invoice attached. Do not open this attachment.

Five things that may surprise you about type 1 diabetes

Professor Liz Davis reveals five things you might not know about type 1 diabetes.

Researchers identify immune cell that puts cancer to sleep

A team of Australian scientists including cancer researchers from The Kids Research Institute Australia have made a crucial breakthrough in understanding how the immune system puts cancer to sleep.

What are the signs my child is being bullied?

More than half of all children who are bullied do not tell anyone.

Cow’s milk protein allergies on the rise in our kids

Up to three out of every 100 babies develop cow's milk protein allergy (CMPA) in their first year of life – and this number appears to be on the rise

New drug therapy provides hope for kids with cystic fibrosis

The family of two girls with cystic fibrosis are hopeful after The Kids Research Institute Australia spin-off company, Respirion, receives $20 million in funding to develop a promising new therapy.